The best way to change the future is to effectively train the leaders of tomorrow and David aims to motivate and challenge future scientific leaders with current biomedical problems we face in society such as discovering new drugs to treat multi-drug resistant and extensively drug-resistant pathogens, understand why some human diseases have limited or no treatment options available to patients and how applied biochemistry can be used to solve these problems. David encourages independent thinking and he enjoys using research to produce original scientific knowledge that can be utilized to generate new biomedical technology. David enjoys teaching medical science and biochemistry subjects at Charles Sturt University.

David’s research focuses on the development of novel therapeutics that target specific proteins with the goal of improving the quality of life for people that suffer from life threatening diseases. David enjoys tackling difficult aspects of early-stage drug discovery with vibrant and rigorous research projects. David’s research interests include the development of novel sterol biosynthesis inhibitors that could be used to treat cancer or parasitic protozoan diseases (Human African Trypanosomiasis & Chagas Disease), the development of synthetic carbohydrate biomimetics as urinary tract infection prophylactics, the synthesis of irreversible enzyme inhibitors that could be used to kill parasitic nematodes, and the optimization of monovalent and multivalent carbohydrate derivatives that could be used to inactivate toxins such as cholera toxin and heat-labile enterotoxin.